Bill Dynan - NAR Cancer Editor
@nar-cancer-editor.bsky.social
Editor of fully Open Access journal publishing articles at the intersection of the nucleic acids research and cancer fields.
NAR Cancer 5th anniversary symposium on manipulating DNA repair and DDR for cancer therapy - 4th and final session, Thursday April 17, noon Eastern. Elise Fouquerel and Rob Sobol on emerging targets. Link to free registration: academic.oup.com/narcancer/pa...
April 15, 2025 at 11:40 AM
NAR Cancer 5th anniversary symposium on manipulating DNA repair and DDR for cancer therapy - 4th and final session, Thursday April 17, noon Eastern. Elise Fouquerel and Rob Sobol on emerging targets. Link to free registration: academic.oup.com/narcancer/pa...
NAR Cancer 5th Anniversary symposium in cooperation with Social DNAing: Thursday, March 13, noon US Eastern. Dale Ramsden on Pol theta and Katie Pawelczak on targeting RPA.
Program info and link to register: academic.oup.com/narcancer/pa...
Program info and link to register: academic.oup.com/narcancer/pa...
March 10, 2025 at 6:55 PM
NAR Cancer 5th Anniversary symposium in cooperation with Social DNAing: Thursday, March 13, noon US Eastern. Dale Ramsden on Pol theta and Katie Pawelczak on targeting RPA.
Program info and link to register: academic.oup.com/narcancer/pa...
Program info and link to register: academic.oup.com/narcancer/pa...
In NAR Cancer: Loss of powerful G4 resolvase FANCJ sensitizes to G4-stabilizing ligand - shown in cancer cells and in C. elegans in vivo. Proof-of-principle for synthetic lethality-based therapeutic approach. Marcello Germoglio et al, IBBC and University of Naples. academic.oup.com/narcancer/ar...
February 14, 2025 at 7:14 PM
In NAR Cancer: Loss of powerful G4 resolvase FANCJ sensitizes to G4-stabilizing ligand - shown in cancer cells and in C. elegans in vivo. Proof-of-principle for synthetic lethality-based therapeutic approach. Marcello Germoglio et al, IBBC and University of Naples. academic.oup.com/narcancer/ar...
Watch the replay - terrific and well attended talks from Kara Bernstein (RAD51 paralogs) and Joanna Loizou (pol theta) yesterday at the NAR Cancer 5th anniversary symposium. Link to "watch the latest replay" at www.cancer.columbia.edu/research/pro...
February 14, 2025 at 6:52 PM
Watch the replay - terrific and well attended talks from Kara Bernstein (RAD51 paralogs) and Joanna Loizou (pol theta) yesterday at the NAR Cancer 5th anniversary symposium. Link to "watch the latest replay" at www.cancer.columbia.edu/research/pro...
This is terrific to see! Proud graduate student Dory Fawwal presents her new NAR Cancer paper to her peers and colleagues. Oncohistone H3E50K. academic.oup.com/narcancer/ar...
February 14, 2025 at 5:15 PM
This is terrific to see! Proud graduate student Dory Fawwal presents her new NAR Cancer paper to her peers and colleagues. Oncohistone H3E50K. academic.oup.com/narcancer/ar...
NAR Cancer 5th anniversary symposium on manipulating DNA repair and the DDR - Session 2 this Thursday, Feb 13, noon US Eastern time. Kara Bernstein and Joanna Loizou speaking. In collaboration with Social DNAing. Information and free registration link at academic.oup.com/narcancer/pa...
February 11, 2025 at 3:56 PM
NAR Cancer 5th anniversary symposium on manipulating DNA repair and the DDR - Session 2 this Thursday, Feb 13, noon US Eastern time. Kara Bernstein and Joanna Loizou speaking. In collaboration with Social DNAing. Information and free registration link at academic.oup.com/narcancer/pa...
NAR Cancer 5th anniversary symposium - fantastic first session today. Ranjit Bindra on development of innovative peptide-drug conjugate CBX-12 and Li Lan on RNA methyltransferase TRDMT1 as an emerging target. Recordings available for a limited time: fast.wistia.com/embed/channe...
January 9, 2025 at 8:55 PM
NAR Cancer 5th anniversary symposium - fantastic first session today. Ranjit Bindra on development of innovative peptide-drug conjugate CBX-12 and Li Lan on RNA methyltransferase TRDMT1 as an emerging target. Recordings available for a limited time: fast.wistia.com/embed/channe...
NAR Cancer 5th anniversary symposium: Manipulating DNA repair and the DNA damage response to improve cancer therapy. First session via Zoom this week, Jan 9, noon US Eastern features Ranjit Bindra (Yale), Li Lan (Duke). Register at columbiacuimc.zoom.us/webinar/regi...
January 7, 2025 at 1:09 PM
NAR Cancer 5th anniversary symposium: Manipulating DNA repair and the DNA damage response to improve cancer therapy. First session via Zoom this week, Jan 9, noon US Eastern features Ranjit Bindra (Yale), Li Lan (Duke). Register at columbiacuimc.zoom.us/webinar/regi...